21![[removed]Federal Register / Vol. 68, No[removed]Tuesday, November 18, [removed]Notices General Function of the Committee: To provide advice and [removed]Federal Register / Vol. 68, No[removed]Tuesday, November 18, [removed]Notices General Function of the Committee: To provide advice and](https://www.pdfsearch.io/img/efc9a91bcccf128a4c639110c8e1247b.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English - Date: 2003-11-18 06:37:42
|
---|
22![DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration Pediatric Advisory Committee; Notice of Meeting AGENCY: ACTION: DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration Pediatric Advisory Committee; Notice of Meeting AGENCY: ACTION:](https://www.pdfsearch.io/img/643a17909b1f42bac9bd3e0ca07beb4b.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English - Date: 2007-10-11 08:11:54
|
---|
23![Treanda (bendamustine hydrochloride) Full Safety and Drug Utilization Review Provided in Background Materials Pediatric Advisory Committee Meeting, September 23, 2014 Treanda (bendamustine hydrochloride) Full Safety and Drug Utilization Review Provided in Background Materials Pediatric Advisory Committee Meeting, September 23, 2014](https://www.pdfsearch.io/img/a76bcb37437ca59ef9347b6d5fceabb7.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
24![Federal Register / Vol. 72, No[removed]Thursday, August 16, [removed]Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. 2007P–0074] Federal Register / Vol. 72, No[removed]Thursday, August 16, [removed]Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. 2007P–0074]](https://www.pdfsearch.io/img/19e271644d720f7ce93fea2b352da77c.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English - Date: 2007-08-16 07:39:39
|
---|
25![Microsoft Word - AGENDA BRUDAC_Sept 18v2.doc Microsoft Word - AGENDA BRUDAC_Sept 18v2.doc](https://www.pdfsearch.io/img/c014516815918fad1efc437b12fa4547.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
26![DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. 2007P[removed]Joint Meeting of the Nonprescription Drugs Advisory Committee and the Pediatric Advisory Committee; Notice of Meeting DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. 2007P[removed]Joint Meeting of the Nonprescription Drugs Advisory Committee and the Pediatric Advisory Committee; Notice of Meeting](https://www.pdfsearch.io/img/c162ed543c23d5a4f0f0dcbda353091b.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English - Date: 2007-08-14 16:44:15
|
---|
27![Federal Register / Vol. 79, No[removed]Thursday, October 9, [removed]Notices Mendrick at least 7 days in advance of the meeting. FDA is committed to the orderly conduct of its advisory committee meetings. Please visit our W Federal Register / Vol. 79, No[removed]Thursday, October 9, [removed]Notices Mendrick at least 7 days in advance of the meeting. FDA is committed to the orderly conduct of its advisory committee meetings. Please visit our W](https://www.pdfsearch.io/img/e657f2b0be21fe4f50d2899af850d7a0.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
28![FDA Briefing Document Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee (ODAC) November 1, 2011 DISCLAIMER STATEMENT FDA Briefing Document Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee (ODAC) November 1, 2011 DISCLAIMER STATEMENT](https://www.pdfsearch.io/img/8d642f20696e91dcaad573ce32760eee.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
29![Pediatric Oncology Subcommittee of the Oncology Drugs Advisory Committee – Food and Drug Administration Open Session Meeting on Optimizing the Development of Oncology and Hematology Drugs for Pediatric Use MK-3475 Pedi Pediatric Oncology Subcommittee of the Oncology Drugs Advisory Committee – Food and Drug Administration Open Session Meeting on Optimizing the Development of Oncology and Hematology Drugs for Pediatric Use MK-3475 Pedi](https://www.pdfsearch.io/img/b859cf670b944a978a2460f568d9051f.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
30![FDA Briefing Document Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee (ODAC) November 4, 2013 DISCLAIMER STATEMENT FDA Briefing Document Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee (ODAC) November 4, 2013 DISCLAIMER STATEMENT](https://www.pdfsearch.io/img/985adb65f2da32ab01b3e44caed118e2.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|